Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Asan Medical Center
With
OBJECTIVES: Primary * To assess the safety of donor natural killer (NK) cell infusion after HLA-mismatched/haploidentical allogeneic hematopoietic stem cell transplantation from a familial donor in patients with advanced malignant disorders. * To determine the maximum number of donor NK cells that can be safely given to these patients. Secondary * To assess the clinical efficacy donor NK cell infusion, in terms of tumor response, response duration, and survival, in patients with progressive or recurrent malignant disorders. OUTLINE: This is a phase I, dose-escalation study followed by a phase II study. * Phase I: Patients receive an infusion of donor natural killer (NK) cells on days 18 and 21. * Phase II: Patients receive an infusion of donor NK cells on days 14 and 21. After completion of study treatment, patients are followed periodically.
Age
15–75
Sex
ALL
Healthy volunteers
Not accepted
